Get started
Author

Martin Schulz

Observed name: M. Schulz
ORCID: 0000-0001-8357-8710
Observed ORCID: 0000-0001-8357-8710
OpenAlex ID: A5011416049
Durability of transgene expression after rAAV gene therapy
2022 · Manish Muhuri, Daniel I. Levy, et al. · Molecular Therapy · 163
PDF
Binding and neutralizing anti-AAV antibodies: Detection and implications for rAAV-mediated gene therapy
2023 · Martin Schulz, Daniel I. Levy, et al. · Molecular Therapy · 136
Complement activation in a phase Ib study of fordadistrogene movaparvovec for Duchenne muscular dystrophy
2025 · Barry J. Byrne, Russell J. Butterfield, et al. · Molecular Therapy · 19
Strengthening health systems for access to gene therapy in rare genetic disorders
2024 · Sonal Bhatia, Yann Le Cam, et al. · Molecular Therapy — Methods & Clinical Development · 11
PDF
Haemo PREF : Further evaluation of patient perception and preference for treatment in a real world setting
2017 · S. Bonanad, M. Schulz, et al. · Haemophilia · 7
Safety and efficacy of nonacog alfa for the treatment of haemophilia B in children younger than 6 years of age in a routine clinical care setting: the EUREKIX registry study
2020 · Ri Liesner, Nadine G. Andersson, et al. · Haemophilia · 3
PDF
How long do the effects of gene therapy based on adeno-associated virus last? A plain language summary
2024 · Tara Moroz, Manish Muhuri, et al. · Future Rare Diseases · 2
A plain language summary of AAV-based gene therapy: challenges and potential solutions for people with antibodies against AAV
2023 · Tara Moroz, Martin Schulz, et al. · Future Rare Diseases · 2
Evaluating Patient Preference for Haemophilia a Treatment
2016 · Martin Schulz, Ana Gordo, et al. · Blood · 1
Development of a medication report in collaboration with general practitioners and community pharmacists
2026 · Laura Katharina Lepenies, Viktoria Sophie Wurmbach, et al. · Exploratory Research in Clinical and Social Pharmacy
PDF
The suitability of the 15-STARS tool to screen for non- adherence of analgesic medications in patients with chronic pain
2026 · Natyra Gashi, Dardan Hetemi, et al. · Exploratory Research in Clinical and Social Pharmacy
PDF
Rationale for using centralized transduction inhibition assays in three phase 3 rAAV gene therapy clinical trials
2023 · Martin Schulz, George Bashirians, et al. · Molecular Therapy — Methods & Clinical Development
Reply to: Gene therapy to cure haemophilia: Is robust scientific inquiry the missing factor?
2021 · Ian Winburn, Martin Schulz, et al. · Haemophilia
Works count: 13
Citation count: 344
H-index: 5
I10-index: 4
Year
Topic
Type